S100A2 anticorps (full length)

N° du produit ABIN7878955

Cet anticorps anti-S100A2 Monoclonal Souris (Clone S100A2-6925) (ABIN7878955) détecte spécifiquement S100A2 dans IHC (p). L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour S100A2 anticorps (full length) (ABIN7878955)

Antigène: S100A2 (S100 Calcium Binding Protein A2 (S100A2))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp S100A2 est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone: S100A2-6925

Détail du produit anti-S100A2 anticorps

Épitope: full length

Fonction: S100A2 Antibody / S100 Calcium Binding Protein A2

Purification: Protein A/G affinity

Immunogène: Recombinant full-length human protein was used as the immunogen for the S100A2 antibody.

Isotype: IgG2b, kappa

Information d'application

Indications d'application: Optimal dilution of the S100A2 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the S100A2 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur S100A2

Antigène: S100A2 (S100 Calcium Binding Protein A2 (S100A2))

Autre désignation: S100A2

Sujet: S100A2 belongs to the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100A2 may function as a modulator against excess calcium accumulation in normal human mammary epithelial cells and also have a role in suppressing tumor cell growth. This protein may have a tumor suppressor function. Chromosomal rearrangements and altered expression of this gene have been implicated in breast cancer. Cytoplasmic overexpression may also be of prognostic significance when observed in oral cancer patients, and the S100A2 has also been identified as significantly down regulated in gastric cancer.

UniProt: P29034

Pathways: S100 Proteins